Co-Authors
This is a "connection" page, showing publications co-authored by Ketty Peris and Paolo Gisondi.
Connection Strength
0.588
-
Hidradenitis suppurativa and adalimumab in the COVID-19 era. Eur J Dermatol. 2020 Dec 01; 30(6):748-749.
Score: 0.229
-
Consensus on the management of patients with psoriatic arthritis in a dermatology setting. J Eur Acad Dermatol Venereol. 2018 Apr; 32(4):515-528.
Score: 0.187
-
The clinical spectrum of COVID-19-associated cutaneous manifestations: An Italian multicenter study of 200 adult patients. J Am Acad Dermatol. 2021 05; 84(5):1356-1363.
Score: 0.058
-
Characteristic of chronic plaque psoriasis patients treated with biologics in Italy during the COVID-19 Pandemic: Risk analysis from the PSO-BIO-COVID observational study. Expert Opin Biol Ther. 2021 02; 21(2):271-277.
Score: 0.058
-
Management of biological therapies for chronic plaque psoriasis during COVID-19 emergency in Italy. J Eur Acad Dermatol Venereol. 2020 Dec; 34(12):e770-e772.
Score: 0.056